Fluoxetine scaffold to design tandem molecular antioxidants and green catalysts

23Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Fluoxetine finds application in the treatment of depression and mood disorders. This selective serotonin-reuptake inhibitor (SSRI) also contrasts oxidative stress by direct ROS scavenging, modulation of the endogenous antioxidant defense system, and/or enhancement of the serotonin antioxidant capacity. We synthesised some fluoxetine analogues incorporating a selenium nucleus, thus expanding its antioxidant potential by enabling a hydroperoxides-inactivating, glutathione peroxidase (GPx)-like activity. Radical scavenging and peroxidatic activity were combined in a water-soluble, drug-like, tandem antioxidant molecule. Selenofluoxetine derivatives were reacted with H2O2in water, and the mechanistic details of the reaction were unravelled combining nuclear magnetic resonance (NMR), electrospray ionisation-mass spectrometry (ESI-MS) and quantum chemistry calculations. The observed oxidation-elimination process led to the formation of seleninic acid and cinnamylamine in atrans-selective manner. This mechanism is likely to be extended to other substrates for the preparation of unsaturated cinnamylamines.

Cite

CITATION STYLE

APA

Ribaudo, G., Bortoli, M., Ongaro, A., Oselladore, E., Gianoncelli, A., Zagotto, G., & Orian, L. (2020). Fluoxetine scaffold to design tandem molecular antioxidants and green catalysts. RSC Advances, 10(32), 18583–18593. https://doi.org/10.1039/d0ra03509b

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free